MHRA launches pilot project that puts patient involvement at the heart of clinical trials and medicine development

From today, when new applications for selected medicines (new active substances and new indications) are received, the applicant company will be asked for evidence on the patient involvement activities they undertook when developing their product.

Source:

Medicines and Healthcare products Regulatory Agency